节点文献

耐药MTB分离株对不同组合抗结核药品体外药物敏感性试验的结果分析

Clinical analysis of drug sensitivity tests of various drug-resistant MTB isolates against different combinations of anti-tuberculosis drugs in vitro

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 应若嫣黄晓辰王洁刘一典沙巍杨华

【Author】 YING Ruo-yan;HUANG Xiao-chen;WANG Jie;LIU Yi-dian;SHA Wei;YANG Hua;Shanghai Key Laboratory of Tuberculosis,Shanghai Pulmonary Hospital Affiliated to Tongji University;

【通讯作者】 杨华;

【机构】 同济大学附属上海市肺科医院上海市结核病(肺)重点实验室同济大学附属上海市肺科医院结核病临床研究中心

【摘要】 目的分析耐药MTB分离株对不同组合抗结核药品(简称"不同组合药品")进行体外药物敏感性试验(简称"药敏试验")的检测结果,评价不同组合药品的最低抑菌浓度(MIC)及对耐药菌株的抗结核协同作用。方法搜集同济大学附属上海市肺科医院"十二五"国家科技重大专项入组的148例首次复治肺结核患者,通过对患者痰标本进行BACTEC MGIT 960和改良罗氏法培养获取167株MTB分离株,对75例患者经上述两种方法进行药敏试验结果均为阳性的92株耐药菌株(包括36株MDR-MTB、54株XDR-MTB和2株单耐H菌株),采用MIC三维棋盘法分别以H-R、Mfx-Pa、Mfx-Pa-Rfb、Mfx-Pa-Rft等4种组合药品进行体外药敏试验,计算不同药品组合的协同率。结果药品未组合前的H、R、Rfb、Rft、Pa体外药敏试验MIC值的中位数(四分位数)[M(Q1,Q3)]分别为4(1,8)、24(2,64)、0.5(0.125,1)、4(4,4)、8(4,8)mg/L,均明显高于组合后的H[2(1,4)mg/L]、R[1(0.25,16)mg/L]、与Mfx-Pa组合后的Rfb[0.125(0.03125,0.125)mg/L]、与Mfx-Pa组合后的Rft[1(1,1)mg/L]、与Mfx/Mfx-Rfb/Mfx-Rft组合后的Pa[分别为0.0075(0.0075,0.875)、0.0075(0.0075,0.125)、0.0225(0.0075,0.5)mg/L](Z=-4.855,-6.908,-8.386,-8.632,-8.094,-8.335,-7.771,P值均<0.001);且H-R、Mfx-Pa、Mfx-Pa-Rfb、Mfx-Pa-Rft药品组合后的协同率分别为12.0%(11/92)、5.4%(5/92)、17.4%(16/92)、23.9%(22/92);其中H-R和Mfx-Pa组合分别与Mfx-Pa-Rfb和Mfx-Pa-Rft组合的协同率比较,差异均有统计学意义(χ2=12.670,P=0.002;χ2=19.420,P<0.001;χ2=18.640,P<0.001;χ2=28.500,P<0.001)。结论组合药品中H、R、Rfb、Rft、Pa的MIC值均低于未组合前该药品的MIC值,说明耐药菌株对组合后上述药品的敏感性增强。三药组合的协同率均优于两药组合,且Mfx-Pa-Rft较Mfx-Pa-Rfb组合表现出更好的协同作用。

【Abstract】 Objective The results of in vitro drug sensitivity test(drug sensitivity test)of drug-resistant MTB isolates against different combinations of anti-tuberculosis drugs(different combinations of drugs)were analyzed to evaluate the minimum inhibitory concentration(MIC)of different combinations of drugs and the antiMTB synergistic effect on drug-resistant strains. Methods One hundred and forty-eight first retreatment tuberculosis patients participating in the"twelfth five-year"national science and technology key projects undertaken by the Shanghai Pulmonary Hospital affiliated to Tongji University were collected,and 167 MTB isolates were obtained via culturing of sputum samples from patients by BACTEC MGIT 960 and modified Roche separation method.Ninety-two resistant strains(including 36 of MDR-MTB,54 of XDR-MTB,and 2 of single H resistant strains)from 75 patients identified by the above two methods of drug susceptibility test were used to perform the in vitro susceptibility tests of 4 types of drug combinations,including H-R,Mfx-Pa,Mfx-Pa-Rfb and Mfx-Pa-Rft,respectively,through three-dimensional chessboard MIC detection,and the synergistic rates of different drug combinations were calculated. Results The median(quartile)(M(Q1,Q3))of the MIC values of H,R,Rfb,Rft,and Pa before drug combination were 4(1,8),24(2,64),0.5(0.125,1),4(4,4),and 8(4,8)mg/L,respectively,which were significantly higher than that of H(2(1,4)mg/L),R(1(0.25,16)mg/L),and Rfb(0.125(0.03125,0.125)mg/L)after Mfx-Pa combination,Rft(1(1,1)mg/L)after Mfx-Pa combination,Pa(0.0075(0.0075,0.875)mg/L,0.0075(0.0075,0.125)mg/L,and 0.0225(0.0075,0.5)mg/L)combined with Mfx/Mfx-Rfb/Mfx-Rft,respectively(Z=-4.855,-6.908,-8.386,-8.632,-8.094,-8.335,-7.771,all Pvalues<0.001).The synergic rates of H-R,Mfx-Pa,Mfx-Pa-Rfb and Mfx-Pa-Rft were 12.0%(11/92),5.4%(5/92),17.4%(16/92)and 23.9%(22/92),respectively.The difference of the synergic rates between H-R and Mfx-Pa combination to Mfx-Pa-Rfb and Mfx-Pa-Rft combination,respectively,were statistically significant(χ2=12.670,P=0.002;χ2=19.420,P<0.001;χ2=18.640,P<0.001;χ2=28.500,P<0.001). Conclusion The MIC values of H,R,Rfb,Rft and Pa in the combined drugs are lower than those before combination,indicating that the sensitivities to the combined drugs of drug-resistant strains are enhanced.The synergy rates of the three drug combinations are better than that of the two drug combinations,and Mfx-Pa-Rft showed better synergy than Mfx-Pa-Rfb combination.

【基金】 “十三五”国家科技重大专项(2018ZX10722302-004)
  • 【文献出处】 中国防痨杂志 ,Chinese Journal of Antituberculosis , 编辑部邮箱 ,2020年11期
  • 【分类号】R52
  • 【被引频次】1
  • 【下载频次】66
节点文献中: 

本文链接的文献网络图示:

本文的引文网络